 |
|
|
|
|
|
|
|
|
|
|
|
1 to 30 of 38 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Fagan A. on PAPER: Handoko M. et al., 2013, Development of valid and quantitative assays for oligomeric Aβ species is considered by many to... 19 Mar 2013.
|
|
|
 |
|
|
Fagan A. on PAPER: Buchhave P. et al., 2012, The recent paper by Buchhave and colleagues in the Archives of General Psychiatry is, to my... 11 Jan 2012.
|
|
|
|
|
|
Fagan A. on PAPER: Desikan RS. et al., 2011, This paper is a good example of the field taking the biomarker issue to the next level—beyond... 16 Nov 2011.
|
|
|
|
|
|
Fagan A. on NEWS: In the Blood: What Can Plasma Aβ Tell Us About Alzheimer’s?, The Yaffe paper is indeed very interesting. Finding a diagnostic and/or prognostic plasma... 29 Jan 2011.
|
|
|
|
|
|
Fagan A, Holtzman D, Morris J. on PAPER: De Meyer G. et al., 2010, Reply to comment by Wes Ashford
Although it is true that ApoE genotype is associated... 23 Sep 2010.
|
|
|
|
|
|
Fagan A. on PAPER: Hu WT. et al., 2010, In their recent paper in Acta Neuropatholgica, Hu and colleagues investigated whether novel... 30 Mar 2010.
|
|
|
|
|
|
Fagan A. on PAPER: Adams SJ. et al., 2009, Recommendation Only. 7 Sep 2009.
|
|
|
|
|
|
Fagan A. on PAPER: Kuczynski B. et al., 2008, Recommendation Only. 19 May 2008.
|
|
|
|
|
|
Fagan A. on PAPER: Remes AM. et al., 2008, Recommendation Only. 24 Apr 2008.
|
|
|
|
|
|
Fagan A. on PAPER: Karas G. et al., 2007, Recommendation Only. 30 Oct 2007.
|
|
|
|
|
|
Fagan A. on PAPER: Maeda J. et al., 2007, Recommendation Only. 23 Oct 2007.
|
|
|
|
|
|
Fagan A. on PAPER: Ray S. et al., 2007, Recommendation Only. 23 Oct 2007.
|
|
|
|
|
|
Fagan A. on PAPER: Pike KE. et al., 2007, Recommendation Only. 23 Oct 2007.
|
|
|
|
|
|
Fagan A. on PAPER: Apostolova LG. et al., 2007, Recommendation Only. 16 Oct 2007.
|
|
|
|
|
|
Fagan A. on PAPER: Maler JM. et al., 2007, Recommendation Only. 16 Oct 2007.
|
|
|
|
|
|
Fagan A. on NEWS: A Blood Test for AD?, The recent Nature Medicine paper by Ray, Britschgi, Wyss-Coray, and colleagues is the... 15 Oct 2007.
|
|
|
|
|
|
Fagan A. on PAPER: Laferla FM. et al., 2007, Recommendation Only. 26 Jun 2007.
|
|
|
|
|
|
Fagan A. on PAPER: Jankowsky JL. et al., 2007, Recommendation Only. 26 Jun 2007.
|
|
|
|
|
|
Fagan A. on PAPER: Marx J. et al., 2007, Recommendation Only. 26 Jun 2007.
|
|
|
|
|
|
Fagan A. on PAPER: Bowman GL. et al., 2007, Recommendation Only. 1 Jun 2007.
|
|
|
|
|
|
Fagan A. on PAPER: Andersson C. et al., 2008, Recommendation Only. 1 Jun 2007.
|
|
|
|
|
|
Fagan A. on PAPER: Glymour MM. et al., 2007, Recommendation Only. 27 Apr 2007.
|
|
|
|
|
|
Fagan A. on PAPER: Whitwell JL. et al., 2007, Recommendation Only. 21 Mar 2007.
|
|
|
|
|
|
Fagan A. on PAPER: Simonsen AH. et al., 2007, Recommendation Only. 21 Mar 2007.
|
|
|
|
|
|
Fagan A. on PAPER: Bacskai BJ. et al., 2007, Recommendation Only. 21 Mar 2007.
|
|
|
|
|
|
Fagan A. on PAPER: Simonsen AH. et al., 2007, Recommendation Only. 1 Mar 2007.
|
|
|
|
|
|
Fagan A. on PAPER: Scherzer CR. et al., 2007, It is always an interesting prospect that gene expression patterns in blood may have utility as... 18 Jan 2007.
|
|
|
|
|
|
Fagan A. on NEWS: CSF Biomarkers—Maybe You Can See the Forest for the Trees, The novelty of the study by Finehout and colleagues lies in the statistical analyses,... 22 Dec 2006.
|
|
|
|
|
|
Fagan A. on PAPER: Engler H. et al., 2006, Recommendation Only. 21 Nov 2006.
|
|
|
|
|
|
Fagan A. on PAPER: Wyss-Coray T. et al., 2006, Recommendation Only. 18 Sep 2006.
|
|
|
|
|
|
|
1 to 30 of 38 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our upcoming Webinar: 
